“Consequently, the guidance midpoint increased by 75 bps to 3.25% from 2.5%. However, after adjusting for inorganic growth, this implies a modest reduction in the midpoint of organic growth guidance,” said Systematix Shares and Stocks (India). The revised range implies a 1.5–3.5% compound quarterly growth rate over Q3–Q4FY27 and Systematix expects HCL to deliver above-industry growth in FY27.
